Cincor Pharma Inc.

Cincor Pharma Inc.

World Rank (Aug-2026)
7569
World Rank (Jan-05-2024)
7,569
World Rank (Jul-30-2023)
7,569
Market Cap (Jul-30-2023)
1.270 Billion USD
World Rank (Jan-07-2022)
10,873
Headquarters Country
USA
Employee Count
15
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-43 Million USD
Annual Net Income in USD
-50 Million USD
Annual Results for Period Ending
For year ending December-2021
Total Assets in USD
141 Million USD
Total Liabilities in USD
205 Million USD
Total Equity in USD
-64 Million USD
Balance Sheet for Period Ending
As of December-2021
Business Sector
Healthcare
Biopharmaceutical
Biotechnology
Company Website
CINCOR PHARMA, INC.
Company Profile
CinCor Pharma Inc is a clinical stage biopharmaceutical company focused on developing lead clinical candidate, baxdrostat (CIN-107), for the treatment of hypertension and other cardio-renal diseases. The headquarters is in United States.
Founded Year
2018
IPO Year
2022
Stock Exchange
Nasdaq

Share